drugset / Trial / NCT01357031

Study With Amitriptylin to Evaluate the Efficacy of Melatonin in Treatment of Migraine

NCT01357031

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of melatonin 3 mg compared to placebo and amitriptyline 25 mg in the preventive treatment of migraine.

Timeline

Start
2010-05
Primary completion
2011-12
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amitriptyline Small molecule 25 mg
Subject Melatonin Small molecule 3 mg

Indications